These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 10862199)
1. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Borgstein PJ; Meijer S; Pijpers RJ; van Diest PJ Ann Surg; 2000 Jul; 232(1):81-9. PubMed ID: 10862199 [TBL] [Abstract][Full Text] [Related]
2. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124 [TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches. Zengel B; Yararbas U; Sirinocak A; Ozkok G; Denecli AG; Postaci H; Uslu A Tumori; 2013; 99(2):149-53. PubMed ID: 23748806 [TBL] [Abstract][Full Text] [Related]
4. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer? Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer. Gherghe M; Bordea C; Blidaru A Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312 [TBL] [Abstract][Full Text] [Related]
6. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node. Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076 [TBL] [Abstract][Full Text] [Related]
7. Subareolar injection for sentinel lymph node location in breast cancer. Zavagno G; Meggiolaro F; Rossi CR; Casara D; Pescarini L; Marchet A; Denetto V; Baratella P; Lise M Eur J Surg Oncol; 2002 Nov; 28(7):701-4. PubMed ID: 12431465 [TBL] [Abstract][Full Text] [Related]
8. [Sentinel lymphatic node biopsy for breast cancer in practice]. Strnad P; Rob L; Krízová H; Zuntová A; Chod J; Halaska M Ceska Gynekol; 2005 Jul; 70(4):291-5. PubMed ID: 16128130 [TBL] [Abstract][Full Text] [Related]
9. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase. Goyal A; Newcombe RG; Chhabra A; Mansel RE; Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308 [TBL] [Abstract][Full Text] [Related]
10. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656 [TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. Kern KA J Am Coll Surg; 1999 Dec; 189(6):539-45. PubMed ID: 10589589 [TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869 [TBL] [Abstract][Full Text] [Related]
14. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145 [TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer. Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937 [TBL] [Abstract][Full Text] [Related]
16. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy. Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081 [TBL] [Abstract][Full Text] [Related]
17. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485 [TBL] [Abstract][Full Text] [Related]
18. [Interest of periareolar injection for colorimetric detection of sentinel node in breast cancer]. Mignotte H; Treilleux I; Chassagne-Clément C; Bem C; Lopez R; Martin X; Brémond A Bull Cancer; 2000 Jul; 87(7-8):600-3. PubMed ID: 10969216 [TBL] [Abstract][Full Text] [Related]
19. Histologic localization of sentinel lymph node metastases in breast cancer. Diaz LK; Hunt K; Ames F; Meric F; Kuerer H; Babiera G; Ross M; Singletary E; Middleton LP; Symmans WF; Krishnamurthy S; Sahin A; Sneige N; Gilcrease MZ Am J Surg Pathol; 2003 Mar; 27(3):385-9. PubMed ID: 12604895 [TBL] [Abstract][Full Text] [Related]
20. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer. Yararbas U; Argon AM; Yeniay L; Zengel B; Kapkaç M Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]